Cytoskeleton/Ras G-LISA Activation Assay Kit (Colorimetric Based) - 96 assays/96 assays/BK131

价格
¥17400.00
货号:BK131
浏览量:127
品牌:Cytoskeleton
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Details

Product Uses Include

  • Ras signaling pathway studies
  • Ras activation assays with primary cells
  • Studies of Ras activators and inactivators
  • Ras activation assays with limited material
  • High throughput screens for Ras activation

Introduction

With the new Ras G-LISA™ kit you can now measure Ras activation from cell and tissue samples in less than 3 h.  G-LISA™ requires only 1-5% of the material needed for a conventional pull-down assay.  You will also be able to handle large sample numbers and generate quantitative results.  For a more detailed introduction on G-LISA™ assays and a listing of other available G-LISA™ kits, see our main G-LISA™ page.

The Ras G-LISA™ kit contains a Ras GTP-binding protein linked to the wells of a 96 well plate. Active, GTP-bound Ras in cell/tissue lysates will bind to the wells while inactive GDP-bound Ras is removed during washing steps.  The bound active Ras is detected with a Ras specific antibody.  The degree of Ras activation is determined by comparing readings from activated cell lysates versus non-activated cell lysates.  Inactivation of Ras is generally achieved in tissue culture by a serum starvation step (see kit datasheet for more information).  

Kit contents

The kit contains sufficient reagents to perform 96 Ras activation assays. Since the Ras-GTP affinity wells are supplied as strips and the strips can be broken into smaller pieces, each kit can be used for anywhere from one to multiple assays. The following components are included in the kit: 

  1. 96 Ras-GTP affinity wells (divisible into 12 strips of 8 wells each)
  2. Lysis buffer
  3. Binding buffer
  4. Antigen presenting buffer
  5. Wash buffer
  6. Antibody dilution buffer
  7. Anti-Ras antibody
  8. HRP-labeled secondary antibody
  9. Positive control Ras protein
  10. Protease inhibitor cocktail (Cat. # PIC02)
  11. Absorbance detection reagents
  12. Precision Red™ Advanced protein assay reagent (Cat. # ADV02)
  13. Manual with detailed protocols and extensive troubleshooting guide

    Equipment needed

  14. 96-well plate spectrophotometer capable of reading 490 nm wavelength
  15. Multichannel or multidispensing pipettor
  16. Orbital microplate shaker capable of at least 200 rpm shaking (400 rpm is optimal)

Example results

BK131-Fig1

Figure 1.  Ras  activation by EGF measured by G-LISA™.  HeLa cells were serum starved (SS) for 24 h and treated with EGF (100 ng/ml for 2 min). 25,  12.5, 5, 1.25 µg of cell lysates were subjected to the G-LISA™ assay. Absorbance was read at 490 nm.  Data are background subtracted

Go to main G-LISA™ page

G-LISA Products:Cdc42 G-LISA™ Activation Assay, colorimetric format (Cat.# BK127)Rac1 G-LISA™ Activation Assay, luminescence format (Cat.# BK126)G-LISA Rac 1,2,3 Activation Assay Biochem Kit (colorimetric format (Cat.# BK125)RhoA G-LISA™ Activation Assay, colorimetric format (Cat.# BK124)RhoA G-LISA™ Activation Assay, luminescence format (Cat.# BK121)

Associated Products:Anti-Cdc42 monoclonal antibody (Cat.# ACD03)Anti-Rac1 monoclonal antibody (Cat.# ARC03)Anti-RhoA monoclonal antibody (Cat.# ARH03)

About

For product Datasheets and MSDSs please click on the PDF links below.   

  •  G-LISA Activation Assay Technical Guide download here
  •  G-LISA Data Analysis (Absorbance) Excel Template download here.

 

    Citations

    Wang, X., Yao, Y. & Gao, J. Sevoflurane inhibits growth factor-induced angiogenesis through suppressing Rac1/paxillin/FAK and Ras/Akt/mTOR. Futur. Oncol. 16, 1619–1627 (2020).

    Kim, J. H. et al. Rational design of small molecule RHOA inhibitors for gastric cancer. Pharmacogenomics J. 20, 601–612 (2020).

    Chen, G. P., Zhang, X. Q., Wu, T., Han, J. & Ye, D. Inhibition of farnesyl pyrophosphate synthase attenuates high glucose-induced vascular smooth muscle cells proliferation. Mol. Med. Rep. 15, 3153–3160 (2017).

    Lu, H. et al. Research paper resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR. Oncotarget 11, 265–281 (2020).

    Casique-Aguirre, D. et al. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer 06 Biological Sciences 0601 Biochemistry and Cell Biology. BMC Cancer 18, 1–16 (2018).

    Li, Q. fen, Decker-Rockefeller, B., Bajaj, A. & Pumiglia, K. Activation of Ras in the Vascular Endothelium Induces Brain Vascular Malformations and Hemorrhagic Stroke. Cell Rep. 24, 2869–2882 (2018).

    Zhao, T. et al. Simulated Microgravity Reduces Focal Adhesions and Alters Cytoskeleton and Nuclear Positioning Leading to Enhanced Apoptosis via Suppressing FAK/RhoA-Mediated mTORC1/NF-κB and ERK1/2 Pathways. Int. J. Mol. Sci. 19, 1994 (2018).

    S.-J. Lee et al. 2013. Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and krüppel-like factor 5. J. Biol. Chem. 288, 25244-25253.

    L.D. Camargo et al. 2013. Endo-PDI is required for TNFα-induced angiogenesis. Free Radic. Biol. Med. 65, 1398-1407.

    Gil-Henn et al. 2012. Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. Oncogene. doi:10.1038/onc.2012.284.

    Faqs

    Coming soon! If you have any questions concerning this product, please contact our Technical Service department at tservice@cytoskeleton.com

    Cytoskeleton运动蛋白Cytoskeleton Motor Werks™(CMW)产品线由Cytoskeleton独家制造和销售。这些产品促进了运动蛋白领域的研究和药物开发(Funk et al。2005)。我们致力于生产真核和真菌来源的高纯度和具有生物活性的驱动蛋白和肌球蛋白家族蛋白。这些试剂旨在用于抗有丝分裂药物的发现和运动活性的机理研究。Cytoskeleton Motor Werks™系列产品还包含几种Biochem Kits™,抗体和其他与运动相关的试剂(例如,微管稳定剂紫杉醇,目录号TXD01)和蛋白质(例如,预先形成的微管,目录号MT002)。  有关运动蛋白的更多信息,请单击上方的关于标签。  从以下类别中选择:药物和缓冲液F-肌动蛋白丝套件微管蛋白质类